$1.70
0.042.41%
Last update: Nov 10, 8:33 AM
Pyxis Oncology Inc
PYXSNASDAQ
Pyxis Oncology fell 64.4% from $4.77 to $1.70, behind the S&P 500's +10.5%. Its worst day was Dec 18 (−48.7%), and its low came Dec 29 at $1.06.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Pyxis Oncology closed at its highest level of the year, 11.9% above where the year started.
+3.7% · S&P 500 +0.9%
46% confirmed objective response rate (ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg71% confirmed ORR and 100% DCR observed with MICVO in combination with
Story events cover the past 12 months · Times ET
−48.7%, the year's worst day · S&P 500 +0.5%
Pyxis Oncology closed at its lowest level of the year, 77.8% below where the year started.
−4.5% · S&P 500 −0.4%
EPS of $-0.29 beat the $-0.34 estimate on $11.0M revenue.
−3.4% · S&P 500 +1.1%
Pyxis Oncology shares rose 25.7%, while the S&P 500 rose 1.4%.
+25.7%, the year's best day · S&P 500 +1.4%
EPS of $-0.37 missed the $-0.35 estimate on $0.00 revenue.
−15.6% · S&P 500 +0.8%
Pyxis Oncology shares rose 24.2%, while the S&P 500 fell 0.7%.
+24.2% · S&P 500 −0.7%
Pyxis Oncology shares rose 24.8%, while the S&P 500 fell 0.5%.
+24.8% · S&P 500 −0.5%
EPS of $-0.40 missed the $-0.35 estimate on $0.00 revenue (est. $22,220.00).
−5.3% · S&P 500 +0.7%
EPS of $-0.24 beat the $-0.28 estimate on $0.00 revenue.
−3.0% · S&P 500 −4.4%
Where it ended: a close of $1.70 on Nov 9, 2026.
Nothing in the past 12 months.
All PYXS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PYXS and SPY from Benzinga historical bars. Not investment advice.
